Gherghe, M.; Lazăr, A.M.; Stanciu, A.E.; Mutuleanu, M.-D.; Sterea, M.-C.; Petroiu, C.; Galeș, L.N.
The New Radiolabeled Peptide 99mTcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs? Cancers 2022, 14, 2725.
https://doi.org/10.3390/cancers14112725
AMA Style
Gherghe M, Lazăr AM, Stanciu AE, Mutuleanu M-D, Sterea M-C, Petroiu C, Galeș LN.
The New Radiolabeled Peptide 99mTcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs? Cancers. 2022; 14(11):2725.
https://doi.org/10.3390/cancers14112725
Chicago/Turabian Style
Gherghe, Mirela, Alexandra Maria Lazăr, Adina Elena Stanciu, Mario-Demian Mutuleanu, Maria-Carla Sterea, Cristina Petroiu, and Laurenția Nicoleta Galeș.
2022. "The New Radiolabeled Peptide 99mTcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs?" Cancers 14, no. 11: 2725.
https://doi.org/10.3390/cancers14112725
APA Style
Gherghe, M., Lazăr, A. M., Stanciu, A. E., Mutuleanu, M.-D., Sterea, M.-C., Petroiu, C., & Galeș, L. N.
(2022). The New Radiolabeled Peptide 99mTcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs? Cancers, 14(11), 2725.
https://doi.org/10.3390/cancers14112725
